Back to search

Article

Systemic Treatment with Nicotinamide Riboside is Protective in Three Mouse Models of Retinal Degeneration

2019-12-06

Abstract excerpt

Purpose: The retina is highly metabolically active, suggesting that metabolic dysfunction could underlie many retinal degenerative diseases. Nicotinamide adenine dinucleotide (NAD + ) is a cofactor and a co-substrate in several cellular energetic metabolic pathways. Maintaining NAD + levels may be therapeutic in retinal disease since retinal NAD + levels decline with age and during retinal damage or degeneratio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
523555e2-78e7-5bed-9f0c-682933bd2066
DOI
10.1101/866798
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systemic Treatment with Nicotinamide Riboside is Protective in Three Mouse Models of Retinal DegenerationDOI 10.1101/866798
Select a neighboring publication to make it the new centre.